Koshinski Asset Management’s Integra LifeSciences IART Stock Holding History

Koshinski Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,744	Closed	-$176K	–	1210
2022 Q1	$176K	Hold	2,744	–	–	0.01%	631
2021 Q4	$184K	Hold	2,744	–	–	0.01%	652
2021 Q3	$188K	Buy	+2,744	New	+$194K	0.02%	627
2018 Q4	–	Sell	-3,050	Closed	-$201K	–	453
2018 Q3	$201K	Buy	+3,050	New	+$190K	0.03%	502

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Koshinski Asset Management's IART Position: Q2 2022 in Review

Koshinski Asset Management sold out of Integra LifeSciences (IART) in Q2 2022, closing a stake of 2,744 shares — an estimated $176K sold.

Koshinski Asset Management first reported a position in IART in Q3 2018 and held it in 4 quarters. The position peaked at $201K in Q3 2018. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Koshinski Asset Management reported no remaining Integra LifeSciences position as of Q2 2022 after selling out during the quarter.
Koshinski Asset Management sold 2,744 Integra LifeSciences shares in Q2 2022, an estimated $176K.
Koshinski Asset Management first reported a position in Integra LifeSciences in Q3 2018 and held it in 4 quarters.
Koshinski Asset Management's Integra LifeSciences position peaked at $201K in Q3 2018.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.